Prévisions
| Acheter |
0 |
| Conserver |
0 |
| Vendre |
1 |
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
Cofinimmo increases EPRA result by 8.3% and confirms full-year guidance
Cofinimmo reports an EPRA result of €62m for Q1 (+8.3%) and earnings per share of €1.63 (including -€0.12 from disposals). The company confirms its full-year guidance of €6.35 EPRA per share. Occupancy stood at 98.5% at the end of March (healthcare properties 99.4%, distribution networks 99.8%, office properties 93.5%), like-for-like rental growth slowed to 1.1% and office space showed a decline. EPRA NTA rose to €93.98 (+1.1%), the debt ratio fell to 42.1% and Cofinimmo plans net investments of €200m for 2026. » Plus sur de.investing.com
Cofinimmo exceeds Q4 forecasts thanks to strong healthcare portfolio
Cofinimmo reports an EPRA result of €246m for Q4 2025 (+0.7%) and an EPRA result per share of €6.45, thereby beating expectations. The portfolio remains robust, with 77% of portfolio value in healthcare properties and a fair value of €6.1bn. Gross rental income rose by 2.9% on a like‑for‑like basis, the debt ratio stayed stable at 42.8%, and the dividend for 2025 was confirmed at €5.20 per share. Cofinimmo expects further growth in the healthcare segment but cites risks from interest rate fluctuations, macroeconomic volatility and regulatory changes in Europe. » Plus sur de.investing.com
Cofinimmo: healthcare properties drive profit growth and confirm annual guidance
Cofinimmo reports an H1 2025 net result attributable to shareholders of €112m and a net result from core activities of €122m, both above its own forecasts. Healthcare properties account for 77% of the €6bn portfolio and drive like‑for‑like rental growth of almost 3%; the occupancy rate is 98.6% with an average remaining lease term of 13 years. Management confirms the annual guidance (EPRA earnings per share ≥ €6.20; gross dividend €5.20) and points to a loan‑to‑value of 44.4%, very low cost of debt (1.4%) and available credit lines of €866m. The strategic shift toward healthcare properties, geographic diversification and the review of a possible merger with Aedifica are in focus, while 56% of the 2025 disposal target has already been achieved. » Plus sur de.investing.com
Cofinimmo increases profit in Q2 2025 through focus on healthcare real estate
Cofinimmo recorded stable growth in the second quarter of 2025, with EPRA earnings rising by 2.5% to €122 million and a significant jump in profit to €112 million. The strategic focus on healthcare real estate, which now makes up 77% of the portfolio, along with strong developments in Spain and the Netherlands, were key contributors to this success. The company confirmed its annual forecast and believes it is well positioned despite potential challenges such as rising financing costs and integration risks. » Plus sur de.investing.com
Cofinimmo confirms 2025 outlook after solid half-year results
Cofinimmo reported an EPRA result of €122 million for the first half of 2025, marking a 2.4% increase compared to the previous year, while earnings per share slightly declined to €3.19. The company is maintaining its full-year forecast of at least €6.20 per share, despite an expected decrease from the prior year and taking into account the scrip dividend and property sales. The occupancy rate remained high at 98.6%, and like-for-like rental growth was 2.8%. » Plus sur de.investing.com
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursEn 2026, COFINIMMO a déjà versé 5,20 € de dividendes. Le dernier versement a eu lieu en mai.
Données financières
Au dernier trimestre, COFINIMMO a réalisé un chiffre d'affaires de 87,31 M € et un bénéfice net de 53,51 M €
| (EUR) | mars 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 87,31 M | - |
| Bénéfice brut | 80,67 M | - |
| Bénéfice net | 53,51 M | - |
| EBITDA | 63,59 M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 3,26 Md € |
Nombre d'actions | 38,09 M |
Plus haut/bas sur 52 semaines | 85,51 € - 56,67 € |
Rendement du dividende | 6,18 % |
Dividendes TTM | 5,20 € |
Bêta | 0,99 |
Ratio P/E | 10,24 |
Ratio PEG | 0,06 |
Ratio P/B | 0,89 |
Ratio P/S | 7,53 |
Profil de l'entreprise
Cofinimmo acquiert, développe et gère des biens immobiliers locatifs depuis plus de 35 ans. Le groupe possède un portefeuille réparti entre la Belgique, la France, les Pays-Bas, l'Allemagne et l'Espagne, d'une valeur d'environ 4,5 milliards EUR. Attentive aux évolutions sociétales, Cofinimmo a pour mission de mettre à disposition des environnements de soins, de vie et de travail de haute qualité pour ses partenaires-locataires, dont les usagers bénéficient directement. « Caring, Living and Working - Together in Real Estate » traduit l'expression de cette mission. Grâce à son expertise, Cofinimmo a constitué un portefeuille immobilier de santé d'une valeur d'environ 2,6 milliards EUR en Europe. En tant que société indépendante appliquant les plus hauts standards de gouvernance d'entreprise et de développement durable, Cofinimmo propose à ses locataires des services et gère son portefeuille grâce à une équipe d'environ 130 collaborateurs à Bruxelles, Paris, Breda et Francfort. Cofinimmo est cotée sur Euronext Bruxelles (BEL20) et bénéficie du régime des SIR en Belgique (RREC), des SIIC en France et des FBI aux Pays-Bas. Ses activités sont supervisées par la Financial Services and Markets Authority (FSMA), l'autorité de régulation belge.
| Nom | COFINIMMO |
| PDG | Jean-Pierre Hanin |
| Siège social | Brussels,
bu Belgique |
| Site web | |
| Secteur | Immobilier |
| Industrie | REITs diversifiés |
| Introduction en bourse | 04/01/2000 |
| Employés | 145 |
Deep Dive
Symboles boursiers
| Bourse | Symbole |
|---|---|
Euronext | COFB.BR |
Pnk | CFMOF |
Brussels Stock Exchange | COFB.BR |
Frankfurt | COF.F |
Düsseldorf | COF.DU |
London | 0J3X.L |
SIX | COFB.SW |
München | COF.MU |
Wien | COFB.VI |